A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand

Global Public Health

Volumn 7, Issue 9, 2012, Pages 1009-1024

  Newman, Peter A ^a   Roungprakhon, Surachet ^b   Tepjan, Suchon ^a   Yim, Suzy ^a   Walisser, Rachael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b RAJAMANGALA UNIVERSITY OF TECHNOLOGY PHRA NAKHON   (Thailand)

Author keywords

acceptability of healthcare; HIV vaccines; populations at risk; structural interventions; Thailand

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CLINICAL ARTICLE; DRUG COST; DRUG EFFICACY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOWEST INCOME GROUP; MALE; PRIORITY JOURNAL; SOCIAL STIGMA; THAILAND;

ADULT; AIDS VACCINES; COSTS AND COST ANALYSIS; FEMALE; HIV INFECTIONS; HOMOSEXUALITY; HUMANS; INTERVIEWS AS TOPIC; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTITUTION; RISK FACTORS; SOCIAL CONFORMITY; SOCIAL STIGMA; SUBSTANCE ABUSE, INTRAVENOUS; THAILAND;

EID: 84867200424     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2012.692388     Document Type: Article

References (40)

1. Allen, M. and Lau, C.Y. 2008. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention. Social Science & Medicine, 66(4): 945-951.
2. Bechtel, G.A. and Apakupakul, N. 1999. AIDS in southern Thailand: stories of krengjai and social connections. Journal of Advanced Nursing, 29: 471-475.
3. Bonner, S. 2009. Implementation science and urban health research. Journal of Urban Health, 86(2): 157-160.
4. Busza, J.R. 2001. Promoting the positive: responses to stigma and discrimination in Southeast Asia. AIDS Care, 13(4): 441-456.
5. Centers for Disease Control and Prevention (CDC), 2011. National and state vaccination coverage among adolescents aged 13 through 17 years-United States. Morbidity and Morality Weekly Report (MMWR), 60, 1117-1123.
6. Charmaz, K. 2006. Constructing grounded theory: a practical guide through qualitative analysis, Thousand Oaks, CA: Sage.
7. Corbin, J. and Strauss, A. 2008. Basics of qualitative research, 3rd ed, Thousand Oaks, CA: Sage.
8. Creswell, J. and Plano Clark, V. 2007. Designing and conducting mixed methods research, Thousand Oaks, CA: Sage.
9. Danovaro-Holliday, M.C., Wood, A.L. and LeBaron, C.W. 2002. Rotavirus vaccine and the news media, 1987-2001. Journal of the American Medical Association, 287(11): 1455-1462.
10. Grant, R.M., Lama, J.R., Anderson, P.L., McMahan, V., Liu, A.Y., Vargas, L., Goicochea, P., Casapia, M., Guanira-Carranza, J.V., Ramirez-Cardich, M.E., Montoya-Herrera, O., Fernández, T., Veloso, V.G., Buchbinder, S.P., Chariyalertsak, S., Schechter, M., Bekker, L.G., Mayer, K.H., Kallás, E.G., Amico, K.R., Mulligan, K., Bushman, L.R., Hance, R.J., Ganoza, C., Defechereux, P., Postle, B., Wang, F., McConnell, J.J., Zheng, J.H., Lee, J., Rooney, J.F., Jaffe, H.S., Martinez, A.I., Burns, D.N. and Glidden, D. 2010. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363: 2587-2599.
11. Grant, R., Lama, L., Glidden, D. and iPrEx Study Team, 2011. Pre-exposure chemoprophylaxis for prevention of HIV among trans-women and MSM: iPrEx Study. 18th Conference on retroviruses and opportunistic infections, 1 March 2011, Boston. Abstract 92.
12. Human Rights Watch (HRW) and Thai AIDS Treatment Action Group (TTAG), 2007. Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand [online]. Available from: http://www.hivpolicy.org/Library/HPP001367.pdf [ Accessed 4 February 2012 ].
13. IRIN-PlusNews, 2007. Thailand: migrant workers unprotected and uninformed [online]. Available from: http://www.plusnews.org/report.aspx?ReportId=75261 [ Accessed 4 February 2012 ].
14. Jackson, P.A. and Sullivan, G. 1999. Lady boys, tom boys, rent boys: male and female homosexualities in contemporary Thailand, Binghamton, NY: Haworth Press.
15. Jenkins, R.A., Temoshok, L.R. and Virochsiri, K. 1995. Incentives and disincentives to participate in prophylactic HIV vaccine research. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9: 36-42.
16. Kaplan, K. and Kahn, P. 2005. "Thai drug users network, AIDS and human rights: a conversation with Karyn Kaplan". In AIDS vaccine handbook: global perspectives, Edited by: Kahn, P. 191-197. New York, NY: AIDS Vaccine Advocacy Coalition.
17. Matthews, J.E., Stephenson, R. and Sullivan, P.S. 2012. Factors associated with self-reported HBV vaccination among HIV-negative MSM participating in an online sexual health survey: a cross-sectional study. PLoS One, 7(2): e30609 doi:10.1371/journal.pone.0030609
18. Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C. and Wilson, K. 2004. Barriers to participating in an HIV vaccine trial: a systematic review. AIDS, 18(17): 2235-2242.
19. Newman, P.A. 2012. Integrating social and behavioral science in HIV vaccine research: obstacles, opportunities and ways forward. Expert Review of Vaccines, 11(1): 1-3.
20. Newman, P.A., Duan, N., Kakinami, L. and Roberts, K. 2008. What can HIV vaccine trials teach us about dissemination?. Vaccine, 26(20): 2528-2536.
21. Newman, P.A., Duan, N., Rudy, E.T. and Anton, P.A. 2004. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?. AIDS Patient Care and STDs, 18(12): 691-701.
22. Newman, P.A. and Logie, C. 2010. HIV vaccine acceptability: a systematic review and meta-analysis. AIDS, 24(11): 1749-1756.
23. Newman, P.A., Logie, C., James, L., Charles, T., Maxwell, J., Salam, K. and Woodford, M. 2011a. 'Speaking the dialect': understanding public discourse in the aftermath of an HIV vaccine trial shutdown. American Journal of Public Health, 101(9): 1749-1758.
24. Newman, P.A., Lee, S.J., Roungprakhon, S. and Tepjan, S. 2012. Demographic and behavioral correlates of HIV risk among men and transgender women recruited from gay entertainment venues and community-based organizations in Thailand: implications for HIV prevention. Prevention Science. [Published ahead of print]. doi: 10.1007/s11121-012-0275-4
25. Newman, P.A., Roungprakhon, S., Tepjan, S. and Yim, S. 2010. Preventive HIV vaccine acceptability and behavioural risk compensation among high-risk men who have sex with men and transgenders in Thailand. Vaccine, 28(4): 958-964.
26. Newman, P.A., Seiden, D., Roberts, K. and Duan, N. 2009. A small dose of HIV? HIV vaccine mental models and risk communication. Health Education & Behavior, 36(2): 321-333.
27. Newman, P.A., Yim, S., Daley, A., Walisser, R., Halpenny, R., Cunningham, W. and Loutfy, M. 2011b. 'Once bitten, twice shy': participant perspectives in the aftermath of an early HIV vaccine trial termination. Vaccine, 29(3): 451-458.
28. Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J.W., Choopanya, K. and Bangkok Vaccine Evaluation Group. 2006. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. Journal of Infectious Diseases, 194 12, 1661-1671.
29. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J.G., Francis, D.P., Stablein, D., Birx, D.L., Chunsuttiwat, S., Khamboonruang, C., Thongcharoen, P., Robb, M.L., Michael, N.L., Kunasol, P., Kim, J.H. and Investigators, MOPH-TAVEG. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 361(23): 2209-2220.
30. Rogers, E.M. 1995. Diffusion of innovations, 5th ed, New York, NY: Free Press.
31. Rojanapithayakorn, W. and Hanenberg, R. 1996. The 100% condom program in Thailand. AIDS, 10(1): 1-7.
32. Shaffer, N., Chuachoowong, R., Mock, P.A., Bhadrakom, C., Siriwasin, W., Young, N.L., Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chinayon, P., Karon, J., Mastro, T.D. and Simonds, R.J. 1999. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet, 353(9155): 773-780.
33. Shahmanesh, M., Patel, V., Mabey, D. and Cowan, F. 2008. Effectiveness of interventions for the prevention of HIV and other sexually transmitted infections in female sex workers in resource poor setting: a systematic review. Tropical Medicine and International Health, 13(5): 1-21.
34. Stupiansky, N.W., Alexander, A.B. and Zimet, G.D. 2012. Human papillomavirus vaccine and men: what are the obstacles and challenges?. Current Opinion in Infectious Diseases, 25(1): 86-91.
35. Sumartojo, E. 2000. Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS, 14(Suppl 1): S10-S13.
36. Suraratdecha, C., Ainsworth, M., Tangcharoensathien, V. and Whittington, D. 2005. The private demand for an AIDS vaccine in Thailand. Health Policy, 71: 271-287.
37. van Griensven, F., Varangrat, A., Wimonsate, W., Tanpradech, S., Kladsawad, K., Chemnasiri, T., Suksripanich, O., Phanuphak, P., Mock, P., Kanggarnrua, K., McNicholl, J. and Plipat, T. 2010. Trends in HIV prevalence, estimated HIV incidence and risk behavior among men who have sex with men in Bangkok, Thailand, 2003-2007. Journal of Acquired Immune Deficiency Syndromes, 53(2): 234-239.
38. Walensky, R.P., Paltiel, A.D., Goldie, S.J., Gandhi, R.T., Weinstein, M.C., Seage, G.R., Smith, H.E., Zhang, H. and Freedberg, K.A. 2004. A therapeutic HIV vaccine: how good is good enough?. Vaccine, 22(29-30): 4044-4053.
39. Weinberg, G.A. and Szilagyi, P.G. 2010. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. Journal of Infectious Diseases, 20(11): 1607-1610.
40. WHO, 2008. HIV/AIDS care and treatment for people who inject drugs in Asia and the Pacific: an essential practice guide [online]. Available from: http://www.who.int/hiv/pub/idu/searo_wpro_essential/en/index.html [ Accessed 4 February 2012 ].